Background: Photochemotherapy (PUVA) is beneficial for the treatment of var
ious dermatoses, The introduction of ultraviolet B and narrow-band ultravio
let B phototherapy has had a significant impact on the role of PUVA in derm
atology, This study aims to assess the current role of PUVA in treating der
matoses, in a predominantly Asian population, at the National Skin Centre i
n Singapore,
Materials and methods: We reviewed the clinical data of 115 patients who we
re started on PUVA treatment at the National Skin Centre, Singapore in 1998
. We analysed the epidemiology data, the clinical response rate and the adv
erse effects of PUVA therapy, All of the patients continued to have ongoing
maintenance treatment.
Results: Most of our patients were Chinese (74.8%) and male (58.3%), rangin
g from the ages of 4 to 74 years, Vitiligo (60.9%) was the commonest skin d
isorder treated with PUVA, followed by psoriasis (20.9%), endogenous eczema
(11.3%), mycosis fungoides (3.5%), lichen amyloidosis (2.6%) and prurigo n
odularis (0.9%), Most of our patients received paint PUVA (50.4%), 33.9% or
al PUVA and 15.7% bath PUVA, The best clinical response - those patients ac
hieving a greater that 50% clearance - was observed in patients with endoge
nous eczema, psoriasis and mycosis fungoides (76.8%, 73.9% and 60%, respect
ively), Of the vitiliginous patients, 54.3% experienced a poor response to
PUVA therapy. The main side effects were mild erythema and pruritus,
Conclusion: PUVA remains a valuable, well-tolerated therapeutic option for
a variety of dermatoses.